{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T11:15:29Z","timestamp":1784546129603,"version":"3.55.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,10,30]],"date-time":"2014-10-30T00:00:00Z","timestamp":1414627200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2014,10,30]],"date-time":"2014-10-30T00:00:00Z","timestamp":1414627200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Genes Immun"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1038\/gene.2014.59","type":"journal-article","created":{"date-parts":[[2014,10,30]],"date-time":"2014-10-30T09:57:22Z","timestamp":1414663042000},"page":"99-102","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Variations of the perforin gene in patients with chronic inflammatory demyelinating polyradiculoneuropathy"],"prefix":"10.1038","volume":"16","author":[{"given":"S","family":"Buttini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Cappellano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Ripellino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Briani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Cocito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Osio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Cantello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U","family":"Dianzani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Comi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,10,30]]},"reference":[{"key":"BFgene201459_CR1","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1038\/nri1983","volume":"6","author":"I Voskoboinik","year":"2006","unstructured":"Voskoboinik I, Smyth MJ, Trapani JA . Perforin-mediated target-cell death and immune homeostasis. Nat Rev Immunol 2006; 6: 940\u2013952.","journal-title":"Nat Rev Immunol"},{"key":"BFgene201459_CR2","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1111\/j.0105-2896.2010.00896.x","volume":"235","author":"I Voskoboinik","year":"2010","unstructured":"Voskoboinik I, Dunstone MA, Barran K, Whisstock JC, Trapani JA . Perforin: structure, function, and role in human immunopathology. Immunol Rev 2010; 235: 35\u201354.","journal-title":"Immunol Rev"},{"key":"BFgene201459_CR3","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1111\/j.1365-2141.2004.05305.x","volume":"128","author":"H Katano","year":"2005","unstructured":"Katano H, Cohen JI . Perforin and lymphohistiocytic proliferative disorders. Br J Haematol 2005; 128: 739\u2013750.","journal-title":"Br J Haematol"},{"key":"BFgene201459_CR4","doi-asserted-by":"publisher","first-page":"3079","DOI":"10.1182\/blood-2006-02-001412","volume":"108","author":"R Clementi","year":"2006","unstructured":"Clementi R, Chiocchetti A, Cappellano G, Cerutti E, Ferretti M, Orilieri E et al. Variations of the perforin gene in patients with autoimmunity\/lymphoproliferation and defective Fas function. Blood 2006; 108: 3079\u20133084.","journal-title":"Blood"},{"key":"BFgene201459_CR5","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.2337\/db07-0947","volume":"57","author":"E Orilieri","year":"2008","unstructured":"Orilieri E, Cappellano G, Clementi R, Cometa A, Ferretti M, Cerutti E et al. Variations of the perforin gene in patients with type 1 diabetes. Diabetes 2008; 57: 1078\u20131083.","journal-title":"Diabetes"},{"key":"BFgene201459_CR6","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1038\/gene.2008.35","volume":"9","author":"G Cappellano","year":"2008","unstructured":"Cappellano G, Orilieri E, Comi C, Chiocchetti A, Bocca S, Boggio E et al. Variations of the perforin gene in patients with multiple sclerosis. Genes Immun 2008; 9: 438\u2013444.","journal-title":"Genes Immun"},{"key":"BFgene201459_CR7","doi-asserted-by":"publisher","first-page":"2803","DOI":"10.1016\/S0024-3205(03)00196-6","volume":"72","author":"U Dianzani","year":"2003","unstructured":"Dianzani U, Chiocchetti A, Ramenghi U . Role of inherited defects decreasing Fas function in autoimmunity. Life Sci 2003; 72: 2803\u20132824.","journal-title":"Life Sci"},{"key":"BFgene201459_CR8","doi-asserted-by":"publisher","first-page":"483","DOI":"10.2337\/diabetes.50.3.483","volume":"50","author":"S DeFranco","year":"2001","unstructured":"DeFranco S, Bonissoni S, Cerutti F, Bona G, Bottarel F, Cadario F et al. Defective function of Fas in patients with type 1 diabetes associated with other autoimmune diseases. Diabetes 2001; 50: 483\u2013488.","journal-title":"Diabetes"},{"key":"BFgene201459_CR9","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1212\/WNL.55.7.921","volume":"55","author":"C Comi","year":"2000","unstructured":"Comi C, Leone M, Bonissoni S, DeFranco S, Bottarel F, Mezzatesta C et al. Defective T cell fas function in patients with multiple sclerosis. Neurology 2000; 55: 921\u2013927.","journal-title":"Neurology"},{"key":"BFgene201459_CR10","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1111\/j.1085-9489.2006.00063.x","volume":"11","author":"C Comi","year":"2006","unstructured":"Comi C, Gaviani P, Leone M, Ferretti M, Castelli L, Mesturini R et al. Fas-mediated T-cell apoptosis is impaired in patients with chronic inflammatory demyelinating polyneuropathy. J Peripher Nerv Syst 2006; 11: 53\u201360.","journal-title":"J Peripher Nerv Syst"},{"key":"BFgene201459_CR11","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1111\/j.1529-8027.2009.00219.x","volume":"14","author":"C Comi","year":"2009","unstructured":"Comi C, Osio M, Ferretti M, Mesturini R, Cappellano G, Chiocchetti A et al. Defective Fas-mediated T-cell apoptosis predicts acute onset CIDP. J Peripher Nerv Syst 2009; 14: 101\u2013106.","journal-title":"J Peripher Nerv Syst"},{"key":"BFgene201459_CR12","first-page":"201657","volume":"2014","author":"P Ripellino","year":"2014","unstructured":"Ripellino P, Fleetwood T, Cantello R, Comi C . Treatment of chronic inflammatory demyelinating polyneuropathy: from molecular bases to practical considerations. Autoimmune Dis 2014; 2014: 201657.","journal-title":"Autoimmune Dis"},{"key":"BFgene201459_CR13","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1111\/j.1468-1331.2009.02930.x","volume":"17","author":"PY Van den Bergh","year":"2010","unstructured":"Van den Bergh PY, Hadden RD, Bouche P, Cornblath DR, Hahn A, Illa I et al. European Federation of Neurological Societies\/Peripheral Nerve Society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society\u2014first revision. Eur J Neurol 2010; 17: 356\u2013363.","journal-title":"Eur J Neurol"},{"key":"BFgene201459_CR14","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/S1474-4422(10)70041-7","volume":"9","author":"JM Vallat","year":"2010","unstructured":"Vallat JM, Sommer C, Magy L . Chronic inflammatory demyelinating polyradiculoneuropathy: diagnostic and therapeutic challenges for a treatable condition. Lancet Neurol 2010; 9: 402\u2013412.","journal-title":"Lancet Neurol"},{"key":"BFgene201459_CR15","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1111\/j.1085-9489.2006.00061.x","volume":"11","author":"RA Hughes","year":"2006","unstructured":"Hughes RA, Allen D, Makowska A, Gregson NA . Pathogenesis of chronic inflammatory demyelinating polyradiculoneuropathy. J Peripher Nerv Syst 2006; 11: 30\u201346.","journal-title":"J Peripher Nerv Syst"},{"key":"BFgene201459_CR16","doi-asserted-by":"publisher","first-page":"4700","DOI":"10.1182\/blood-2004-12-4935","volume":"105","author":"I Voskoboinik","year":"2005","unstructured":"Voskoboinik I, Thia MC, Trapani JA . A functional analysis of the putative polymorphisms A91V and N252S and 22 missense perforin mutations associated with familial hemophagocytic lymphohistiocytosis. Blood 2005; 105: 4700\u20134706.","journal-title":"Blood"},{"key":"BFgene201459_CR17","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1182\/blood-2004-09-3713","volume":"106","author":"C Trambas","year":"2005","unstructured":"Trambas C, Gallo F, Pende D, Marcenaro S, Moretta L, De Fusco C et al. A single amino acid change, A91V, leads to conformational changes that can impair processing to the active form of perforin. Blood 2005; 106: 932\u2013937.","journal-title":"Blood"},{"key":"BFgene201459_CR18","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1172\/JCI26217","volume":"116","author":"KA Risma","year":"2006","unstructured":"Risma KA, Frayer RW, Filipovich AH, Sumegi J . Aberrant maturation of mutant perforin underlies the clinical diversity of hemophagocytic lymphohistiocytosis. J Clin Invest 2006; 116: 182\u2013192.","journal-title":"J Clin Invest"},{"key":"BFgene201459_CR19","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1182\/blood-2007-02-072850","volume":"110","author":"I Voskoboinik","year":"2007","unstructured":"Voskoboinik I, Sutton VR, Ciccone A, House CM, Chia J, Darcy PK et al. Perforin activity and immune homeostasis: the common A91V polymorphism in perforin results in both pre- and post-synaptic defects in function. Blood 2007; 110: 1184\u20131190.","journal-title":"Blood"},{"key":"BFgene201459_CR20","doi-asserted-by":"publisher","first-page":"441","DOI":"10.3389\/fimmu.2013.00441","volume":"4","author":"I Voskoboinik","year":"2013","unstructured":"Voskoboinik I, Trapani JA . Perforinopathy: a spectrum of human immune disease caused by defective perforin delivery or function. Front Immunol 2013; 4: 441.","journal-title":"Front Immunol"},{"key":"BFgene201459_CR21","doi-asserted-by":"publisher","first-page":"5234","DOI":"10.1182\/blood-2006-12-063495","volume":"109","author":"EE Solomou","year":"2007","unstructured":"Solomou EE, Gibellini F, Stewart B, Malide D, Berg M, Visconte V et al. Perforin gene mutations in patients with acquired aplastic anemia. Blood 2007; 109: 5234\u20135237.","journal-title":"Blood"},{"key":"BFgene201459_CR22","doi-asserted-by":"publisher","first-page":"128","DOI":"10.5847\/wjem.j.issn.1920-8642.2013.02.008","volume":"4","author":"Q Ding","year":"2013","unstructured":"Ding Q, Yang L . Perforin gene mutations in 77 Chinese patients with lymphomas. World J Emerg Med 2013; 4: 128\u2013132.","journal-title":"World J Emerg Med"},{"key":"BFgene201459_CR23","first-page":"1","volume":"198","author":"B Lowin","year":"1995","unstructured":"Lowin B, Peitsch MC, Tschopp J . Perforin and granzymes: crucial effector molecules in cytolytic T lymphocyte and natural killer cell-mediated cytotoxicity. Curr Top Microbiol Immunol 1995; 198: 1\u201324.","journal-title":"Curr Top Microbiol Immunol"},{"key":"BFgene201459_CR24","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/335448a0","volume":"335","author":"MG Lichtenheld","year":"1988","unstructured":"Lichtenheld MG, Olsen KJ, Lu P, Lowrey DM, Hameed A, Hengartner H et al. Structure and function of human perforin. Nature 1988; 335: 448\u2013451.","journal-title":"Nature"},{"key":"BFgene201459_CR25","first-page":"175","volume":"178","author":"ER Podack","year":"1992","unstructured":"Podack ER . Perforin: structure, function and regulation. Curr Top Microbiol Immunol 1992; 178: 175\u2013184.","journal-title":"Curr Top Microbiol Immunol"},{"key":"BFgene201459_CR26","doi-asserted-by":"publisher","first-page":"8426","DOI":"10.1074\/jbc.M413303200","volume":"280","author":"I Voskoboinik","year":"2005","unstructured":"Voskoboinik I, Thia MC, Fletcher J, Ciccone A, Browne K, Smyth MJ et al. Calcium-dependent plasma membrane binding and cell lysis by perforin are mediated through its C2 domain: a critical role for aspartate residues 429, 435, 483, and 485 but not 491. J Biol Chem 2005; 280: 8426\u20138434.","journal-title":"J Biol Chem"},{"key":"BFgene201459_CR27","doi-asserted-by":"publisher","first-page":"5277","DOI":"10.1073\/pnas.082095299","volume":"99","author":"B Li","year":"2002","unstructured":"Li B, Wachtel C, Miriami E, Yahalom G, Friedlander G, Sharon G et al. Stop codons affect 5' splice site selection by surveillance of splicing. Proc Natl Acad Sci USA 2002; 99: 5277\u20135282.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFgene201459_CR28","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1146\/annurev.bi.65.070196.002055","volume":"65","author":"A Kr\u00e4mer","year":"1996","unstructured":"Kr\u00e4mer A . The structure and function of proteins involved in mammalian pre-mRNA splicing. Annu Rev Biochem 1996; 65: 367\u2013409.","journal-title":"Annu Rev Biochem"},{"key":"BFgene201459_CR29","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1038\/ejhg.2013.20","volume":"21","author":"C Dias","year":"2013","unstructured":"Dias C, McDonald A, Sincan M, Rupps R, Markello T, Salvarinova R et al. Recurrent subacute post-viral onset of ataxia associated with a PRF1 mutation. Eur J Hum Genet 2013; 21: 1232\u20131239.","journal-title":"Eur J Hum Genet"},{"key":"BFgene201459_CR30","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1111\/jns5.12074","volume":"19","author":"S Blum","year":"2014","unstructured":"Blum S, McCombe PA . Genetics of Guillain-Barr\u00e9 syndrome (GBS) and chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): current knowledge and future directions. J Peripher Nerv Syst 2014; 19: 88\u2013103.","journal-title":"J Peripher Nerv Syst"},{"key":"BFgene201459_CR31","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/S0166-2236(97)01079-5","volume":"20","author":"R Gold","year":"1997","unstructured":"Gold R, Hartung HP, Lassmann H . T-cell apoptosis in autoimmune diseases: termination of inflammation in the nervous system and other sites with specialized immune-defense mechanisms. Trends Neurosci 1997; 20: 399\u2013404.","journal-title":"Trends Neurosci"},{"key":"BFgene201459_CR32","first-page":"89","volume":"2","author":"G Cappellano","year":"2013","unstructured":"Cappellano G, Carecchio M, Fleetwood T, Magistrelli L, Cantello R, Dianzani U et al. Immunity and inflammation in neurodegenerative diseases. Am J Neurodegener Dis 2013; 2: 89\u2013107.","journal-title":"Am J Neurodegener Dis"},{"issue":"Suppl 1","key":"BFgene201459_CR33","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/j.1529-8027.2011.00306.x","volume":"16","author":"C Comi","year":"2011","unstructured":"Comi C . Fas-mediated T-cell apoptosis in chronic inflammatory demyelinating polyneuropathy. J Peripher Nerv Syst 2011; 16 (Suppl 1): 45\u201347.","journal-title":"J Peripher Nerv Syst"},{"key":"BFgene201459_CR34","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.autrev.2011.08.011","volume":"12","author":"C Comi","year":"2012","unstructured":"Comi C, Fleetwood T, Dianzani U . The role of T cell apoptosis in nervous system autoimmunity. Autoimmun Rev 2012; 12: 150\u2013156.","journal-title":"Autoimmun Rev"},{"key":"BFgene201459_CR35","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1007\/s004010050437","volume":"91","author":"UK Zettl","year":"1996","unstructured":"Zettl UK, Gold R, Toyka KV, Hartung HP . In situ demonstration of T cell activation and elimination in the peripheral nervous system during experimental autoimmune neuritis in the Lewis rat. Acta Neuropathol 1996; 91: 360\u2013367.","journal-title":"Acta Neuropathol"},{"key":"BFgene201459_CR36","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1002\/glia.10235","volume":"43","author":"B Bonetti","year":"2003","unstructured":"Bonetti B, Valdo P, Ossi G, De Toni L, Masotto B, Marconi S et al. T-cell cytotoxicity of human Schwann cells: TNFalpha promotes fasL-mediated apoptosis and IFNgamma perforin-mediated lysis. Glia 2003; 43: 141\u2013148.","journal-title":"Glia"},{"key":"BFgene201459_CR37","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1002\/ana.410440512","volume":"44","author":"RD Hadden","year":"1998","unstructured":"Hadden RD, Cornblath DR, Hughes RA, Zielasek J, Hartung HP, Toyka KV et al. Electrophysiological classification of Guillain-Barr\u00e9 syndrome: clinical associations and outcome. Plasma exchange\/sandoglobulin Guillain-Barr\u00e9 Syndrome Trial Group. Ann Neurol 1998; 44: 780\u2013788.","journal-title":"Ann Neurol"},{"key":"BFgene201459_CR38","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1136\/jnnp.2005.076174","volume":"77","author":"IS Merkies","year":"2006","unstructured":"Merkies IS, Schmitz PI . Getting closer to patients: the INCAT Overall Disability Sum Score relates better to patients\u2019 own clinical judgement in immune-mediated polyneuropathies. J Neurol Neurosurg Psychiatry 2006; 77: 970\u2013972.","journal-title":"J Neurol Neurosurg Psychiatry"}],"container-title":["Genes & Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/gene201459.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/gene201459","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/gene201459.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,22]],"date-time":"2022-03-22T17:06:59Z","timestamp":1647968819000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/gene201459"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10,30]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["BFgene201459"],"URL":"https:\/\/doi.org\/10.1038\/gene.2014.59","relation":{},"ISSN":["1466-4879","1476-5470"],"issn-type":[{"value":"1466-4879","type":"print"},{"value":"1476-5470","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,10,30]]},"assertion":[{"value":"22 June 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2014","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2014","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2014","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}